Progyny, Inc. (PGNY) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	1.3B	1.3B	1.2B	1.1B	786.9M
Cost of Revenue	988.7M	984.2M	913.9M	849.8M	619.6M
Gross Profit	322.1M	304.5M	253.4M	238.8M	167.3M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	210.0M	219.2M	185.9M	176.6M	144.0M
General & Admin Expense	139.1M	147.1M	122.0M	117.1M	98.3M
Selling & Marketing Expense	70.9M	72.1M	63.9M	59.5M	45.7M
Other Expenses	—	—	—	—	—
Total Operating Expenses	210.0M	219.2M	185.9M	176.6M	144.0M
Cost and Expenses	1.2B	1.2B	1.1B	1.0B	763.6M
Operating Income (EBIT)	112.1M	85.3M	67.5M	62.2M	23.3M
Non-Operating
Interest Income	6.6M	10.2M	15.7M	8.5M	814.0K
Interest Expense	—	—	—	—	—
Net Interest Income	6.6M	10.2M	15.7M	8.5M	814.0K
Other Non-Op Income/Expense	7.7M	10.2M	15.7M	8.5M	1.1M
Non-Operating Income (excl Interest)	(7.7M)	(10.2M)	(15.7M)	(8.5M)	(1.1M)
EBT (Pre-Tax Income)	119.8M	95.4M	83.2M	70.7M	24.4M
Income Tax Expense	41.2M	36.9M	28.9M	8.7M	(5.9M)
Bottom Line
Net Income	78.6M	58.5M	54.3M	62.0M	30.4M
Earnings from Cont. Ops	78.6M	58.5M	54.3M	62.0M	30.4M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	78.6M	58.5M	54.3M	62.0M	30.4M
Per Share
Basic EPS	$0.97	$0.68	$0.59	$0.65	$0.33
Diluted EPS	$0.92	$0.65	$0.57	$0.62	$0.30
Revenue Per Share	$16.77	$15.12	$12.76	$11.46	$8.54
Shares
Basic Shares Outstanding	78.2M	85.2M	91.5M	95.0M	92.2M
Diluted Shares Outstanding	82.1M	89.5M	95.4M	100.7M	100.0M
Profitability Metrics
EBITDA	127.1M	100.4M	86.4M	73.0M	26.0M
D&A	7.2M	4.9M	3.2M	2.3M	1.6M
EBIT	119.8M	95.4M	83.2M	70.7M	24.4M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026